Reliance Industries Limited (RIL) is set to declare its first-quarter results for FY27 on Friday, July 17, after market hours, post 3:30 PM. Brokerages expect the conglomerate to post a healthy set of numbers for the June quarter, driven by continued strength in its telecom, retail and oil-to-chemicals (O2C) businesses.

Increased tender offer price exceeds the JPY 3,384 price in the competing proposal and aims to reduce uncertainty and facilitate the timely completion of the transactionAmended tender offer price reflects the Consortium's continued commitment to supporting Kakaku.com's long-term growth and developmentThe Consortium has already obtained all necessary regulatory clearances required, further underscoring the certainty of the transaction for the Company and its shareholders.TOKYO, July 17, 2026 /PRN

The US on Friday launched strikes against Iran for 6th night in a row. It said the strikes were carried out to "further degrade Iranian military capabilities". | World News

Polycab shares extended losses for a third straight session despite a Q1 earnings beat, driven by strong wires and cables growth and a surge in the FMEG business, with brokerages remaining bullish on its growth outlook.

European shares decline as escalating Middle East tensions and tech stock selloffs weigh on markets. The STOXX 600 index dropped 0.6%, while tech stocks led declines. Despite some strong earnings, the sector suffered losses. Luxury markets showed some gains, but tourism was impacted by regional conflicts.

Kioxia's stock has halved from its peak, while Samsung and SK Hynix have each shed about a third of their value as Asia's AI chip rally cools.

Olin Corporation and Huntsman Corporation announced that on July 13, 2026, the U.S. Securities and Exchange Commission declared effective the registration statement on Form S-4 (the "Registration Statement") filed by Olin in connection with the previously announced all-stock merger of equals (the "Transaction") to form a combined company, OlinHuntsman. The companies have also released a supplemental FAQ which contains further details regarding the synergies expected to be achieved from the Trans

GlucoTrack shares jumped 15.98% after-hours as investors reacted to Lokahi Therapeutics merger news and restructuring plans.